| Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma (NCT00863369) | City of Hope Medical Center | 2005-06-29 |
| A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a (NCT00117013) | National Cancer Institute (NCI) | 2005-06-28 |
| SPECT Study With SB-773812 In Schizophrenic Patients (NCT00269035) | GlaxoSmithKline | 2005-06-21 |
| Effect of Clonidine on Responses to Imagery Scripts (NCT00318760) | National Institute on Drug Abuse (NIDA) | 2005-06-14 |
| Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis (NCT00356642) | GlaxoSmithKline | 2005-06-10 |
| A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) (NCT00127127) | Merck Sharp & Dohme LLC | 2005-06-10 |
| Ropinirole Tablets In Young Patients With Restless Legs Syndrome (NCT00140712) | GlaxoSmithKline | 2005-06-10 |
| AEG35156 and Docetaxel in Treating Patients With Solid Tumors (NCT00357747) | NCIC Clinical Trials Group | 2005-06-09 |
| Vaccine and Antibody Treatment of Prostate Cancer (NCT00113984) | National Cancer Institute (NCI) | 2005-06-08 |
| Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer (NCT00121251) | National Cancer Institute (NCI) | 2005-06-03 |
| Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing (NCT00856934) | Centre Hospitalier Universitaire Vaudois | 2005-06-01 |
| Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants (NCT00265005) | University of Louisville | 2005-06-01 |
| Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD (NCT00320775) | Regeneron Pharmaceuticals | 2005-06-01 |
| Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections (NCT00130221) | Cook County Health | 2005-06-01 |
| Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions (NCT00829426) | Teva Pharmaceuticals USA | 2005-06-01 |
| Efalizumab for Moderate to Severe Atopic Dermatitis (NCT00226057) | Oregon Health and Science University | 2005-06-01 |
| Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment (NCT00449137) | University of Miami | 2005-06-01 |
| A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) (NCT00127140) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer (NCT00313534) | University of California, San Francisco | 2005-06-01 |
| Study of ADH-1 Given Intravenously to Patients With Solid Tumors (NCT00265057) | Adherex Technologies, Inc. | 2005-06-01 |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant (NCT00376480) | Dana-Farber Cancer Institute | 2005-06-01 |
| Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer (NCT00295880) | Masonic Cancer Center, University of Minnesota | 2005-06-01 |
| Staccato Alprazolam Single Dose PK (NCT00444522) | Alexza Pharmaceuticals, Inc. | 2005-06-01 |
| Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) (NCT00117429) | Marcus Altfeld, M.D., Ph.D. | 2005-06-01 |
| Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00253344) | Case Comprehensive Cancer Center | 2005-06-01 |
| Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00477750) | Mayo Clinic | 2005-06-01 |
| Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) (NCT00217373) | National Cancer Institute (NCI) | 2005-06-01 |
| An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots (NCT00214812) | Biosyn | 2005-06-01 |
| SPC2996 in Chronic Lymphocytic Leukaemia (NCT00285103) | Santaris Pharma A/S | 2005-06-01 |
| To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions (NCT00881634) | Sandoz | 2005-06-01 |
| Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers (NCT02256748) | Boehringer Ingelheim | 2005-06-01 |
| Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone (NCT00137891) | Genzyme, a Sanofi Company | 2005-06-01 |
| BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma (NCT00126646) | MedImmune LLC | 2005-06-01 |
| Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors (NCT00588276) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528 (NCT00116168) | MedImmune LLC | 2005-06-01 |
| A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study (NCT02392845) | Hospices Civils de Lyon | 2005-06-01 |
| A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients (NCT00190671) | Eli Lilly and Company | 2005-06-01 |
| Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes (NCT00306072) | Ross Products | 2005-06-01 |
| Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia (NCT00131989) | National Cancer Institute (NCI) | 2005-06-01 |
| Use of Multiphoton Microscopy in the Diagnosis of Cancer (NCT00652210) | Weill Medical College of Cornell University | 2005-06-01 |
| Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity (NCT00264186) | Medical University of Vienna | 2005-06-01 |
| A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1 (NCT00239148) | OPKO Health, Inc. | 2005-06-01 |
| Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects (NCT02259868) | Boehringer Ingelheim | 2005-06-01 |
| Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors (NCT00110032) | National Cancer Institute (NCI) | 2005-06-01 |
| Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00556621) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-06-01 |
| Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis (NCT01502137) | Novo Nordisk A/S | 2005-06-01 |
| Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. (NCT00199888) | Ludwig Institute for Cancer Research | 2005-06-01 |
| A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures (NCT00233012) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-06-01 |
| Serotonergic Modulation of Motor Function in Subacute and Chronic SCI (NCT01788969) | Shirley Ryan AbilityLab | 2005-06-01 |
| Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) (NCT00407719) | Johns Hopkins University | 2005-06-01 |
| Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women (NCT00136643) | Laval University | 2005-06-01 |
| Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma (NCT00450307) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037) | OHSU Knight Cancer Institute | 2005-06-01 |
| Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets (NCT00195936) | Children's Mercy Hospital Kansas City | 2005-06-01 |
| The SUUBI Program: Asset-Ownership for Orphaned Children in Uganda (NCT01163695) | Columbia University | 2005-06-01 |
| Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot (NCT00114608) | University at Buffalo | 2005-06-01 |
| Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia (NCT00802620) | Federal University of São Paulo | 2005-06-01 |
| Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease (NCT00252850) | Sangamo Therapeutics | 2005-06-01 |
| Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg (NCT00649454) | Mylan Pharmaceuticals Inc | 2005-06-01 |
| To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets (NCT00946608) | Sandoz | 2005-06-01 |
| Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection (NCT00124215) | GlobeImmune | 2005-06-01 |
| Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers (NCT00133757) | Centre for Addiction and Mental Health | 2005-06-01 |
| Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT00253513) | OHSU Knight Cancer Institute | 2005-06-01 |
| Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma (NCT00418327) | Gustave Roussy, Cancer Campus, Grand Paris | 2005-06-01 |
| Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00128700) | European Organisation for Research and Treatment of Cancer - EORTC | 2005-06-01 |
| Safety and Dosing Evaluation of REG1 Anticoagulation System (NCT00113997) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-06-01 |
| Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies (NCT00129337) | Peregrine Pharmaceuticals | 2005-06-01 |
| Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) (NCT00411580) | Novartis Pharmaceuticals | 2005-06-01 |
| Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease (NCT00692562) | Fuzhou General Hospital | 2005-06-01 |
| Study of Velcade and Thalidomide in Patients With Myelodysplasia (NCT00271804) | Massachusetts General Hospital | 2005-06-01 |
| Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma (NCT00113204) | Infinity Pharmaceuticals, Inc. | 2005-06-01 |
| Evaluation of Whether Functional Strength Training Can Enhance Motor Recovery of the Upper Limb After Stroke (NCT00360789) | St George's, University of London | 2005-06-01 |
| Enteral Glutamine Supplementation for the Patient With Major Torso Trauma (NCT00178581) | The University of Texas Health Science Center, Houston | 2005-06-01 |
| Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary (NCT00201734) | Ohio State University Comprehensive Cancer Center | 2005-06-01 |
| Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women (NCT00163033) | Pantarhei Bioscience | 2005-06-01 |
| Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease (NCT00178438) | University of Rochester | 2005-06-01 |
| Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma (NCT00397800) | Technical University of Munich | 2005-06-01 |
| Phase I Study of Nimotuzumab in Solid Tumours (NCT00369252) | YM BioSciences | 2005-06-01 |
| Effect of Yohimbine on Colon Transit (NCT00217048) | Mayo Clinic | 2005-06-01 |
| The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes (NCT01832766) | University of Colorado, Denver | 2005-06-01 |
| MK0457 in Patients With Leukemia (0457-003) (NCT00111683) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids (NCT00170053) | Mayo Clinic | 2005-06-01 |
| An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend (NCT00150319) | Pfizer | 2005-06-01 |
| A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol (NCT01408589) | University of Colorado, Boulder | 2005-06-01 |
| Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma (NCT00257465) | AVAX Technologies | 2005-06-01 |
| Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model (NCT00172939) | National Taiwan University Hospital | 2005-06-01 |
| Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing (NCT00116285) | Allergy Therapeutics | 2005-06-01 |
| Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX (NCT01367483) | Bausch Health Americas, Inc. | 2005-06-01 |
| Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fasted Conditions (NCT00939536) | Torrent Pharmaceuticals Limited | 2005-06-01 |
| Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model (NCT00468585) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema (NCT00915837) | SurModics, Inc. | 2005-06-01 |
| Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006 (NCT00119639) | Bayer | 2005-06-01 |
| Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging (NCT00453817) | University Hospital, Geneva | 2005-06-01 |
| Effectiveness of Rituximab in Pediatric OMS Patients. (NCT00244361) | National Pediatric Neuroinflammation Organization, Inc. | 2005-06-01 |
| Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy (NCT00456833) | Novartis Pharmaceuticals | 2005-06-01 |
| Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions (NCT00830024) | Teva Pharmaceuticals USA | 2005-06-01 |
| Rapamycin in Advanced Cancers (NCT00707135) | University of Chicago | 2005-06-01 |
| Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill Children (NCT01083407) | Federal University of São Paulo | 2005-06-01 |
| The Effect of HealthWear on Short-Term Weight Loss (NCT00177593) | University of Pittsburgh | 2005-06-01 |
| A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump (NCT00115973) | Novo Nordisk A/S | 2005-06-01 |